Keystone Symposia Scientific Advisory Board
The Scientific Advisory Board (SAB) is comprised of eminent biomedical scientists whose expertise derives from academia, industry, and the government. The SAB is tasked with guiding the development of the conference portfolio, prioritizing content and topics, and providing a substantive peer review process to ensure Keystone Symposia's reputation as the preeminent convener of scientific conferences in the biomedical and life sciences.
To learn more about the functions of the SAB, please click here.
Board of Directors are denoted with a # following their name.|
E. Dale Abel, M.D., Ph.D.#
William S. Adams Professor of Medicine Chair and Executive Medical Director Department of Medicine David Geffen School of Medicine and UCLA Health Clement Adebamowo, B.M., Ch.B., Hons, Sc.D. Professor Epidemiology and Public Health Associate Director Population Science, Greenebaum Comprehensive Cancer Center Member, Institute of Human Virology University of Maryland School of Medicine Karen Adelman, Ph.D. Professor Biological Chemistry and Molecular Pharmacology Harvard Medical School Zoltan Arany, M.D., Ph.D. Professor Medicine University of Pennsylvania Eric H. Baehrecke, Ph.D. Professor Molecular, Cell and Cancer Biology University of Massachusetts Medical School Yasmine Belkaid, Ph.D. Director NIAID Microbiome Program Chief Mucosal Immunology Section Laboratory of Parasitic Disease NIAID, National Institutes of Health Morris J. Birnbaum, M.D., Ph.D.# Retired CSO Pfizer, Inc. Ralph A. Bradshaw, Ph.D.# Professor Emeritus Department of Physiology and Biophysics University of California, Irvine Esther Breij, Ph.D. Vice President, Head of Translational Research Genmab Cherié Butts, Ph.D.# Medical Director Digital & Quantitative Medicine Biogen, Inc. Jonathan D. Chesnut, Ph.D. Senior Director, Cell Biology R&D Life Sciences Solutions Group Thermo Fisher Scientific Ian M. Colrain, Ph.D.# President and CEO MRIGlobal Roger D. Cone, Ph.D. Director Life Sciences Institute University of Michigan Feng Cong, Ph.D. Director Chemical Biology & Therapeutics Novartis Institutes for BioMedical Research Thomas Conlon, Ph.D. Chief Scientific Officer Michelson Philanthropies, Michelson Found Animals Foundation, Inc., & Michelson Medical Research Foundation Kizzmekia S. Corbett-Helaire, Ph.D. Assistant Professor of Immunology and Infectious Diseases Harvard T.H. Chan School of Public Health Carolyn B. Coyne, Ph.D. Professor Molecular Genetics and Biology Duke University Ana Maria Cuervo, M.D., Ph.D. Professor, Department of Developmental and Molecular Biology Co-Director, Institute for Aging Studies Albert Einstein College of Medicine Chi Van Dang, M.D., Ph.D.# Professor Ludwig Institute for Cancer Research Department of Oncology Johns Hopkins University School of Medicine Robertus de Bruin, Ph.D. Vice Dean (EDI), Faculty of Life Sciences Professor of Molecular Cancer Biology Laboratory for Molecular Cell Biology University College London Weiwen Deng, Ph.D. Principal Scientist Amgen, Inc. Edward A. Dennis, Ph.D.# Chancellor Distinguished Professor Chemistry, Biochemistry and Pharmacology School of Medicine University of California, San Diego Suzanne Devkota, Ph.D. Associate Professor Karsh Division of Gastroenterology Cedars-Sinai Medical Center Anwesha Dey, Ph.D. Director Discovery Oncology Genentech, Inc. Richard D. DiMarchi, Ph.D.# Distinguished Professor Chemistry Indiana University Jessica L. Dunne, Ph.D. Scientific Director, T1D Novo Nordisk Aris N. Economides, Ph.D. Vice President Research Regeneron Pharmaceuticals, Inc. Sandra J. Engle, Ph.D. Senior Director Translational Biology Biogen, Inc. Stacey D. Finley, Ph.D. Gordon S. Marshall Early Career Chair and Associate Professor University of Southern California Patrick Finn, Ph.D. Senior Director Rare Diseases Moderna Kelly A. Frazer, Ph.D. Director, Institute for Genomic Medicine Professor of Pediatrics Division Chief, Genome Information Sciences University of California San Diego School of Medicine Maria C. Freire, Ph.D.# Principal The Freire Group Mattias Fyrenius# Publishing Director Bonnier Carlsen Dmitry I. Gabrilovich, M.D., Ph.D. Chief Scientist Cancer Immunology AstraZeneca Stephan Gasser, Ph.D. Senior Principal Scientist CIT-4 Roche Innovation Center Zurich Jason E. Gestwicki, Ph.D. Professor University of California, San Francisco Geoffrey S. Ginsburg, M.D., Ph.D. Chief Medical and Scientific Officer All of Us Research Program Division of Medical and Scientific Research National Institutes of Health Margaret A. Goodell, Ph.D.# Professor and Chair Department of Molecular and Cellular Biology Director of Stem Cells & Regenerative Medicine Center Vivian L. Smith Chair of Regenerative Medicine Baylor College of Medicine Curtis C. Harris, M.D.# Chief, Laboratory of Human Carcinogenesis NCI / National Institutes of Health Lora K. Heisler, Ph.D. Chair in Human Nutrition Obesity and Food Choice Rowett Institute, University of Aberdeen Michael J. Holtzman, M.D. Selman and Herman Seldin Professor, Medicine Director, Pulmonary and Critical Care Medicine Professor, Cell Biology and Physiology Washington University in St. Louis President, NuPeak Therapeutics Prisca Honore, Ph.D. Executive Director Immunology Discovery AbbVie |
Tony Hunter, Ph.D.#
Professor and Principal Investigator Molecular Cellular Biology Laboratories The Salk Institute for Biological Sciences Stefan Irion, M.D. Vice President CNS Research Neurology BlueRock Therapeutics Aron B. Jaffe, Ph.D. Senior Vice President, Head of Research Chroma Medicine Deborah L. Johnson, Ph.D.# President and Chief Executive Officer Keystone Symposia on Molecular and Cellular Biology Véronique Kiermer, Ph.D.# Chief Scientific Officer Editorial Public Library of Science (PLOS) Katherine W. Klinger, Ph.D. Global Head Translational Sciences Sanofi Jean K. Lim, Ph.D. Associate Professor Microbiology Icahn School of Medicine at Mount Sinai Patrick Mayes, Ph.D. Executive Director Immuno-Oncology Antibodies Incyte Research Institute Laura F. Michael, Ph.D. Associate Vice President Diabetes and Complications Therapeutic Area Eli Lilly and Company Valerie Mizrahi, Ph.D. Director Institute of Infectious Disease and Molecular Medicine (IDM) University of Cape Town Walter H. Moos, Ph.D.# Managing Director, Pandect Bioventures Professor (adj), University of California, San Francisco President (ret), SRI Biosciences, Stanford Research Institute Chairman (emer), ShangPharma Innovation Lily Y. Moy, Ph.D. Director, Pharmacology Quantitative Biosciences Merck & Co. Anne N. Murphy, Ph.D. Vice President, Biology Cytokinetics, Inc. Shruti Naik, Ph.D. Assistant Professor, Pathology New York University Langone Health Lee A. Niswander, Ph.D. Professor and Chair Molecular, Cellular and Developmental Biology University of Colorado Boulder Anne O'Garra, Ph.D., FRS, FMedSci# Senior Group Leader The Francis Crick Institute Deborah Palliser, Ph.D. Immunology Strategy Lead Rare Diseases Drug Discovery Unit Takeda Manu Omar Platt, Ph.D. Director, Center for Biomedical Engineering Technology Acceleration Senior Investigator, NIBIB National Institutes of Health Laszlo Radvanyi, Ph.D. President and Scientific Director Ontario Institute for Cancer Research Richard M. Ransohoff, M.D. Venture Partner Third Rock Ventures Rino Rappuoli, Ph.D. Scientific Director National Institute for Pandemic Preparedness (NIPP) Fondazione Biotecnopolo di Siena Wendy Kimryn Rathmell, M.D., Ph.D.# Professor and Chair Medicine Vanderbilt University Medical Center Bing Ren, Ph.D. Professor Ludwig Institute for Cancer Research Christopher J. Rhodes, BSc, PhD Chief Scientist, Cardiovascular, Renal & Metabolism, BioPharmaceuticals R&D, AstraZeneca Professor, University of Chicago Ann-Marie T. Richard, Ph.D. Director, Patient Engagement Internal Medicine Research Unit Pfizer Frank Rigo, Ph.D. Vice President Functional Genomics and Drug Discovery Ionis Pharmaceuticals Mark Rolfe, Ph.D. Senior Vice President Oncogenesis Thematic Research Center Bristol Myers Squibb Pamela C. Ronald, Ph.D. Distinguished Professor Plant Pathology and the Genome Center University of California, Davis Carla V. Rothlin, Ph.D. Professor Immunobiology Yale University Deepak Sampath, Ph.D. Vice President, Head of Research Ultragenyx Terry Lee Sheppard, Ph.D.# Chief Scientific Officer Keystone Symposia on Molecular and Cellular Biology Boris Striepen, Ph.D. Professor of Microbiology and Immunology Department of Pathobiology School of Veterinary Medicine University of Pennsylvania Lori Sussel, Ph.D.# Professor and Director of Research Basic and Translational Research Division, Barbara Davis Center University of Colorado Anschutz Medical Campus Paul K.H. Tam, ChM Chair Professor & VP, Macau University of Science and Technology Emeritus Professor, and Honorary Clinical Professor of Surgery, The University of Hong Kong Cormac Taylor, Ph.D. Professor, Cellular Physiology Medicine University College Dublin Cornelia Liu Trimble, M.D. Professor Gynecology and Obstetrics, Oncology, and Pathology Johns Hopkins University School of Medicine Fred Van Goor, Ph.D. Principal Research Fellow Research Vertex Pharmaceuticals Incorporated Elizabeth Villa, Ph.D. Associate Professor University of California, San Diego Amy J. Wagers, Ph.D. Professor Stem Cell and Regenerative Biology Harvard University Stephanie Wengert Watts, Ph.D. Professor, Assistant Dean Pharmacology & Toxicology Michigan State University Mary E. Wilson, M.D. Professor Internal Medicine and Microbiology & Immunology University of Iowa and the Iowa City VA Medical Center Joseph C. Wu, M.D., Ph.D.# Professor Medicine Stanford University Juleen R. Zierath, Ph.D.# Professor Department of Molecular Medicine and Surgery Karolinska Institutet Arturo Zychlinsky, Ph.D. Director Cellular Microbiology Max Planck Institute for Infection Biology plus representatives to be announced from: Bill & Melinda Gates Foundation BioLegend, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Cell Research Curie.Bio Cystic Fibrosis Foundation GlaxoSmithKline Janssen R&D: Pharmaceutical Companies of Johnson & Johnson Sensei Biotherapeutics TCR² Therapeutics |
